Evidence map›Paper›PMID 23057591›Full record

ArticleJournal of proteome research2012

Low-salt diet and cyclosporine nephrotoxicity: changes in kidney cell metabolism.

Jelena Klawitter, Jost Klawitter, Volker Schmitz, Nina Brunner, Amanda Crunk, Kyler Corby, Jamie Bendrick-Peart, Dieter Leibfritz, Charles L Edelstein, Joshua M Thurman and 1 more

Abstract read
In one paragraph

Article in Journal of proteome research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. The Many Faces of Calcineurin Inhibitor Toxicity-What the FK?Advances in chronic kidney disease · 2020
    Review
  9. Article
  10. Function of CD147 in atherosclerosis and atherothrombosis.Journal of cardiovascular translational research · 2015
    Review
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Jelena Klawitter *Department of Anesthesiology, University of Colorado, Aurora, Colorado, USA.
Jost Klawitter *Department of Anesthesiology, University of Colorado, Aurora, Colorado, USA.
Volker Schmitz *Department of Anesthesiology, University of Colorado, Aurora, Colorado, USA.
Nina BrunnerDepartment of Anesthesiology, University of Colorado, Aurora, Colorado, USA.
Amanda CrunkDepartment of Anesthesiology, University of Colorado, Aurora, Colorado, USA.
Kyler CorbyDepartment of Anesthesiology, University of Colorado, Aurora, Colorado, USA.
Jamie Bendrick-PeartDepartment of Anesthesiology, University of Colorado, Aurora, Colorado, USA.
Dieter LeibfritzInstitute for Organic Chemistry, Universität Bremen, Bremen, Germany.
Charles L EdelsteinDivision of Renal Diseases and Hypertension, University of Colorado, Aurora, Colorado, USA.
Joshua M ThurmanDivision of Renal Diseases and Hypertension, University of Colorado, Aurora, Colorado, USA.
Uwe ChristiansDepartment of Anesthesiology, University of Colorado, Aurora, Colorado, USA.
University of Colorado Anschutz Medical Campus · USUniversity of Colorado Denver · USUniversity of Bremen · DE

Funding

PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Wendy M Kohrt · 1995 to 2026
$32.6M
Effects of Immunosuppressants on Cell MetabolismR01DK065094 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI CHRISTIANS, UWE · 2003 to 2006
$1.2M
NIDDK NIH HHS P30 DK048520NIDDK NIH HHS R01 DK065094
6 · The paper itself

Abstract

Cyclosporine (CsA) is a highly effective immunosuppressant used in patients after transplantation; however, its use is limited by nephrotoxicity. Salt depletion is known to enhance CsA-induced nephrotoxicity in the rat, but the underlying molecular mechanisms are not completely understood. The goal of our study was to identify the molecular effects of salt depletion alone and in combination with CsA on the kidney using a proteo-metabolomic strategy. Rats (n = 6) were assigned to four study groups: (1) normal controls, (2) low-salt fed controls, (3) 10 mg/kg/d CsA for 28 days on a normal diet, (4) 10 mg/kg/d CsA for 28 days on low-salt diet. Low-salt diet redirected kidney energy metabolism toward mitochondria as indicated by a higher energy charge than in normal-fed controls. Low-salt diet alone reduced phospho-AKT and phospho-STAT3 levels and changed the expression of ion transporters PDZK1 and CLIC1. CsA induced macro- and microvesicular tubular epithelial vacuolization and reduced energy charge, changes that were more significant in low-salt fed animals, probably because of their more pronounced dependence on mitochondria. Here, CsA increased phospho-JAK2 and phospho-STAT3 levels and reduced the phospho-IKKγ and p65 proteins, thus activating NF-κB signaling. Decreased expression of lactate transport regulator CD147 and phospho-AKT was also observed after CsA exposure in low-salt rats, indicating a decrease in glycolysis. In summary, our study suggests a key role for PDZK1, CD147, JAK/STAT, and AKT signaling in CsA-induced nephrotoxicity and proposes mechanistic explanations on why rats fed a low-salt diet have higher sensitivity to CsA.

Indexed as

AnimalsBlotting, WesternCyclosporineElectrophoresis, Gel, Two-DimensionalGluconeogenesisGlycolysisImmunosuppressive AgentsIon TransportKidneyMagnetic Resonance SpectroscopyMaleOxidative StressPhosphatesProteomicsRatsRats, WistarCyclosporineImmunosuppressive AgentsPhosphatesSodium Chloride, Dietary

Identifiers

PMID23057591
PMCPMC3831655
OpenAlexW2018968940

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.